Wednesday, February 08, 2012
NAMSA, recently announced the opening of its newest office located near Frankfurt, Germany, which is staffed to provide clinical research and consulting services throughout Europe. This new location will serve clients seeking regulatory approval to market medical devices in Europe, in addition to providing regulatory and clinical trial support to European companies seeking clearance from the U.S. Food and Drug Administration.